Resources from us to you. Right at your fingertips.


Article | PPRX-1701, a nanoparticle formulation of 6- bromoindirubin acetoxime, improves delivery and shows efficacy in preclinical GBM models

Glioblastoma (GBM) is a malignant brain tumor that remains among the most formidable cancers.Despite a well-established standard of care of maximal surgical resection followed by radiotherapy plus concomitant temozolomide (TMZ), median survival remains approximately 15 months.

Read more